| __timestamp | MorphoSys AG | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9689000 | 24518692 |
| Thursday, January 1, 2015 | 10431000 | 19886580 |
| Friday, January 1, 2016 | 9618000 | 12631689 |
| Sunday, January 1, 2017 | 12348000 | 21977998 |
| Monday, January 1, 2018 | 28310241 | 20759000 |
| Tuesday, January 1, 2019 | 59336147 | 20838000 |
| Wednesday, January 1, 2020 | 159145941 | 121812000 |
| Friday, January 1, 2021 | 199800000 | 152137000 |
| Saturday, January 1, 2022 | 90225000 | 83231000 |
| Sunday, January 1, 2023 | 92538000 | 122706000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, TG Therapeutics, Inc. and MorphoSys AG have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, MorphoSys AG's SG&A expenses surged by over 850%, peaking in 2021. Meanwhile, TG Therapeutics, Inc. saw a more modest increase of approximately 500% during the same period, with a notable spike in 2020. This divergence highlights differing strategic priorities and market responses. While MorphoSys AG's expenses reflect aggressive expansion, TG Therapeutics' steadier growth suggests a more conservative approach. As both companies navigate the complexities of the biotech sector, their SG&A trajectories offer valuable insights into their operational strategies and market positioning.
Selling, General, and Administrative Costs: Eli Lilly and Company vs MorphoSys AG
Breaking Down SG&A Expenses: Johnson & Johnson vs TG Therapeutics, Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs TG Therapeutics, Inc.
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? TG Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: TG Therapeutics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MorphoSys AG
Selling, General, and Administrative Costs: MorphoSys AG vs HUTCHMED (China) Limited
Who Optimizes SG&A Costs Better? MorphoSys AG or Wave Life Sciences Ltd.
Cost Management Insights: SG&A Expenses for MorphoSys AG and Amphastar Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: MorphoSys AG vs Novavax, Inc.
MorphoSys AG and Evotec SE: SG&A Spending Patterns Compared